Hai-feng Yu

发表

Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.

Wen-guang Wu, P. Dong, Ying-bin Liu, 2012, World journal of gastroenterology.

[Efficacy of GDP regimen (gemcitabine, dexamethasone, and cisplatin) on relapsed or refractory aggressive non-Hodgkin's Lymphoma: a report of 24 cases].

Hai-feng Yu, Yun Fan, Zhiyu Huang, 2008, Ai zheng = Aizheng = Chinese journal of cancer.

Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas

Hai-feng Yu, Yun Fan, L. Fang, 2011, Acta Pharmacologica Sinica.

Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma

Hai-feng Yu, Yun Zhang, Tian-Zhou Zha, 2012, Tumor Biology.

Defunctioning stoma in low anterior resection for rectal cancer: a meta- analysis of five recent studies.

Ze-Kun Zhao, Hai-feng Yu, Dao-rong Wang, 2011, Hepato-gastroenterology.

High RSF-1 expression correlates with poor prognosis in patients with gastric adenocarcinoma.

Hai-feng Yu, Tian-Zhou Zha, G. Zhao, 2012, International journal of clinical and experimental pathology.

Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer.

Jun Liu, Hai-feng Yu, Dao-rong Wang, 2011, Clinical and investigative medicine. Medecine clinique et experimentale.

High RIN1 expression is associated with poor prognosis in patients with gastric adenocarcinoma

Hai-feng Yu, Dao-rong Wang, Zhi-jun Ge, 2012, Tumor Biology.

Growth and extracellular polysaccharides production of nostoc flagelliforme cells in mixotrophic culture

S. Jia, Hai-feng Yu, Yong-sheng Dong, 2010, 2010 3rd International Conference on Biomedical Engineering and Informatics.

Recent advances of imidazole-containing derivatives as anti-tubercular agents.

Hai-feng Yu, Lian-Shun Feng, X. Jin, 2018, European journal of medicinal chemistry.

High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy

Ke Chen, Hai-feng Yu, Jia-hong Dong, 2012, Tumor Biology.

Stage III should be subclassified into Stage IIIA and IIIB in the American Joint Committee on Cancer (8th Edition) staging system for pancreatic cancer

Hai-feng Yu, Rong-Wei Xu, Yong-Cheng Li, 2018, World journal of gastroenterology.

Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer

Sheng-lin Ma, Yun Fan, Shenglin Ma, 2010, Acta Pharmacologica Sinica.